Journal Basic Info

  • Impact Factor: 1.995**
  • H-Index: 8
  • ISSN: 2474-1647
  • DOI: 10.25107/2474-1647
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Cardiovascular Surgery
  •  General Surgery
  •  Minimally Invasive Surgery
  •  Endocrine Surgery
  •  Gynecological Surgery
  •  Plastic Surgery
  •  Robotic Surgery
  •  Pediatric Surgery

Abstract

Citation: Clin Surg. 2018;3(1):2059.Research Article | Open Access

Effect of Prophylactic Transcatheter Arterial Chemoembolizationon the Recurrence Rate of Hepatocellular Carcinoma with Microvascular Invasion after R0 Resection

Ke-Yue Li, Shuai-min Zhang, Cheng-Xian Shi, Ke-li Tang and Jian-zhao Huang

Department of Hepatobiliary Surgery, Guizhou Provincial People’s Hospital, China

*Correspondance to: Ke-Yue Li 

 PDF  Full Text DOI: 10.25107/2474-1647.2059

Abstract

Objective: We investigated the effect of preventive Transcatheter Arterial Chemoembolization (TACE) in preventing recurrence of Hepatocellular Carcinoma (HCC) after R0 resection.Methods: We retrospectively analyzed recurrence rates over time for 250 cases of HCC after R0 resection, who were divided into patients who underwent TACE (TACE+) and had Microvascular Invasion(MVI+; n=80); TACE+ but did not have MVI (MIV-; n=100); MVI+ but did not undergo TACE (TACE-, n=30); or TACE-/MVI- (n=40).Results: Among both TACE+ and TACE- patients, MVI- patients had significantly lower recurrence rates at 2(29/100, 29% and 15/40, 37.5%) and 3(40/100, 40.0% and 21/40, 52.5%) years after their procedures than did MVI+ patients (35/80, 43.8% and 20/30, 66.7%; 44/80, 55% and 23/30, 76.7%); the TACE- patients also had lower recurrence rates in the 1st year (9/40, 22.5% vs. 14/30, 46.7%), (all P<0.05). Among MVI+ patients, the TACE+ group had significantly lower recurrence rates at 1(20/80, 25.0%), 2(35/80, 43.8%) and 3(44/80, 55.0%) years than the TACE- group (14/30, 46.7% and 20/30, 66.7% and 23/30, 76.7%), (all P<0.05). Recurrence rates in the MVI-patients tended to be lower at 1(20/100, 20.0%), 2(29/100, 29.0%) and 3(40/100, 40.0%) years for the TACE+ group (9/40, 22.5% and 15/40, 37.5% and 21/40, 52.5%), but not significantly so (all P>0.05).Conclusion: Recurrence rates for MVI+ patients were significantly higher than for MVI- patients. Postoperative adjuvant TACE may be beneficial for HCC patients with MVI.

Keywords

Hepatocellular carcinoma; Transcatheter arterial chemoembolization; Microvascular invasion; R0 resection; Recurrence

Cite the article

Li K-Y, Zhang S-M, Shi C-X, Tang K-l, Huang J-Z. Effect of Prophylactic Transcatheter Arterial Chemoembolizationon the Recurrence Rate of Hepatocellular Carcinoma with Microvascular Invasion after R0 Resection. Clin Surg. 2018; 3: 2059.

Search Our Journal

Journal Indexed In

Articles in PubMed

Monitoring an Ongoing Enhanced Recovery after Surgery (ERAS) Program: Adherence Improves Clinical Outcomes in a Comparison of Three Thousand Colorectal Cases
 PubMed  PMC  PDF  Full Text
Voice Outcomes in Laryngotracheal Stenosis: Impact of the Montgomery T-tube
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Use of the Intrathoracic Tube for Repositioning Free Flap Pedicle via Transoral Approach
 Abstract  PDF  Full Text
Melatonin Attenuates Ischemia/Reperfusion Injury of Rat Flap through the Rip3-Mlkl-Mptp Necroptotic Pathway
 Abstract  PDF  Full Text
View More...